Workflow
Cloud-based solution
icon
Search documents
Guidewire Set to Report Q3 Earnings: Here's What Investors Should Know
ZACKS· 2025-06-02 14:01
Core Insights - Guidewire Software, Inc (GWRE) is expected to report third-quarter fiscal 2025 results, with management projecting revenues between $283 million and $289 million, and a Zacks Consensus Estimate of $285.7 million, reflecting an 18.7% year-over-year increase [1][3] - The consensus estimate for earnings per share is 46 cents, unchanged over the past 60 days, compared to 26 cents per share in the same quarter last year [1][3] Revenue and Earnings Expectations - GWRE anticipates subscription and support revenues of $178 million and services revenues of $52 million, with modest sequential growth in subscription revenues due to three fewer calendar days in the quarter [5][7] - Non-GAAP operating income is projected to be between $36 million and $42 million, with subscription gross margin expected to be 68-69% [7][8] Market Performance and Growth Drivers - GWRE has experienced a trailing four-quarter earnings surprise of 40.2% on average, and its shares have increased by 96.1% over the past year, outperforming the Internet-Software industry's growth of 35% [3][4] - The company's performance is likely supported by strong demand for cloud-based solutions and a robust deal volume, particularly among Tier 1 insurers, as well as increasing international momentum in regions like Asia Pacific and Europe [3][4][6] Annual Recurring Revenue (ARR) and Margins - For Q3 fiscal 2025, ARR is expected to be between $942 million and $947 million, with an estimate of $944.6 million [8] - The non-GAAP gross margin for subscription and support is anticipated to be 68.7%, with operating income estimated at $39 million, representing an 87.8% year-over-year increase [9] Challenges and Considerations - The company faces challenges from increasing investments in product enhancements and potential impacts from global macroeconomic conditions and inflation, which may affect license revenues due to the migration of on-premise customers to the cloud [9][10]
SS&C (SSNC) FY Conference Transcript
2025-05-13 21:30
SS&C (SSNC) FY Conference May 13, 2025 04:30 PM ET Speaker0 Great. Hello everyone. My name is Alexey Gogolov, and today I'm delighted to welcome at our Boston TMC conference SS and C CFO, Brian Shell, and company IR, Chand Madaca. Wonderful to see you both at our conference. And, I hope that you, Brian and Chand, are getting along well since that Broncos Chiefs game back in January. And speaking of competition, Brian, maybe you could start by elaborating a bit more on the competitive environment for each of ...
Hospital Information Systems Market Analysis Report 2025: Focus on EHR, CDSS, Specialty, Diagnostic, Pharmacy, Quality, SCM, PHM, RCM, Data Analytics, Telehealth - Global Forecast to 2030
GlobeNewswire News Room· 2025-05-13 14:51
Dublin, May 13, 2025 (GLOBE NEWSWIRE) -- The "Hospital Information Systems Market by Component (Service, Software), Product Type (EHR, CDSS, Specialty, Diagnostic, Pharmacy, Quality, SCM, PHM, RCM, Data Analytics, Telehealth), Deployment (on-Premises, Cloud-Based), Region - Global Forecast to 2030" has been added to ResearchAndMarkets.com's offering. The global hospital information systems market is projected to reach USD 116.75 billion by 2030 from USD 63.80 billion in 2024, at a CAGR of 10.6% from 2024 t ...
Wolters Kluwer First-Quarter 2025 Trading Update
Globenewswire· 2025-05-07 06:00
Core Insights - Wolters Kluwer reported a solid start to 2025 with sustained growth in recurring revenues and margin improvement, reaffirming full-year guidance [4][8][17] Financial Performance - First-quarter revenues increased by 8% in reporting currencies, with organic growth of 5% compared to 6% in 1Q 2024 [5] - Recurring revenues, which constitute 83% of total revenues, grew by 7% organically, consistent with the previous year [5] - Non-recurring revenues declined by 2% organically, with notable growth in Financial & Corporate Compliance and Legal & Regulatory transactional revenues [5][9][10] - Adjusted operating profit increased by 11% at constant currencies, while adjusted free cash flow rose by 5% [8] Segment Performance - Health revenues grew by 3% in constant currencies and 4% organically, with Clinical Solutions achieving 5% organic growth [6] - Tax & Accounting revenues increased by 8% in constant currencies and 5% organically, with cloud software subscriptions growing by 19% [7] - Corporate Performance & ESG revenues saw a 10% increase in constant currencies and organically, driven by strong growth in EHS & ESG solutions [11] Cash Flow and Debt - Cash conversion improved modestly, with adjusted free cash flow increasing by 5% in constant currencies [12] - Net debt stood at €3,347 million as of March 31, 2025, with a net-debt-to-EBITDA ratio of 1.7x [13] Shareholder Returns - The company completed €286 million of its planned €1 billion share buyback program as of May 5, 2025 [8][14] - A proposed total dividend of €2.33 for financial year 2024 represents a 12% increase compared to the previous year [15] Guidance and Outlook - Full-year 2025 guidance remains unchanged, with expectations for organic growth in line with prior year [17][21][22] - Adjusted operating profit margin is anticipated to improve, particularly in Health and Corporate Performance & ESG [17]